Regulatory Capture in the Age of Covid-19

Our healthcare system is broken, a fact nobody would have disputed in pre-COVID days. Regulatory capture is a reality, and the pharmaceutical industry is fraught with examples. Yet we trusted private-public partnerships to find an optimal solution to a global pandemic, assuming a crisis would bring out the best in historically corrupt institutions. Here is a brief list of less-than-savory behavior demonstrated by our titans of healthcare: Pfizer and J&J plead guilty to “misbranding with the intent to defraud or mislead” and paying “kickbacks to health care providers to induce them to prescribe [their] drugs”, resulting in fines of $2.3 billion in … Continue reading Regulatory Capture in the Age of Covid-19